Biomarkers – News and Features

Article
Advances in Biomarker Discovery: From Disease Detection to Cure
This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.

News
Protein That Helps Cancer Cells Dodge CAR T-Cell Therapy Uncovered
City of Hope researchers discovered YTHDF2, a protein enabling blood cancers to evade CAR T cell therapy by hiding critical antigens. They developed CCI-38, a compound that suppresses YTHDF2, enhancing CAR T therapy's success.

News
Faster Epigenetic Aging Tied to Increased Frailty in Later Life
Researchers found that accelerated biological aging, measured via DNA methylation, predicts frailty, cognitive decline, and dementia risk. Females experience memory loss, while males show slowed mental processing and nearly double the dementia risk.

Industry Insight
Role of Biobanking in Protecting Sample Chain of Custody
This blog series will examine current and foreseen challenges for biobanks, as well as the systems and practices that mitigate these challenges.

Industry Insight
Mobile App Uses Your Face To Record Digital Biomarkers of Lung Disease
Technology Networks had the pleasure of speaking with Dr. Bipin Patel, CEO and founder at electronRx, to learn more about how digital biomarkers could help patients suffering from chronic respiratory disorders.

News
Model Enables the Study of Age-Specific Responses to mRNA Vaccines in a Dish
Researchers find answers to why older people had a somewhat reduced immune response to the mRNA vaccines administered during the COVID-19 pandemic when compared with younger adults.

News
Sex Differences in Cancer Biology, Risk and Treatment Documented
A groundbreaking new database could lead to vast improvements in precision oncology by documenting sex-based differences in cancer treatment efficacy, biomarkers, risk factors, and microbial influences across 71 cancer types.

Article
Clinical Proteomics: Progress and Future Prospects With Professor Jennifer Van Eyk
Professor Jennifer Van Eyk joined Technology Networks for an exclusive interview at HUPO 2024 to discuss progress and bottlenecks in clinical proteomics

News
Potential Drug Targets for Diabetic Kidney Disease Identified
New potential therapeutic targets have been identified for diabetic kidney disease, the leading cause of kidney failure worldwide.

News
Repurposed Drug Shows Promise for Lung Cancer
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS mutations, researchers showed.
Advertisement